Catharus ustulatus isolate bCatUst1 chromosome 13, bCatUst1.pri.v2, whole genome shotgun sequence.
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Archelosauria; Archosauria; Dinosauria; Saurischia; Theropoda; Coelurosauria; Aves; Neognathae; Passeriformes; Turdidae; Catharus.
REFSEQ INFORMATION: The reference sequence is identical to\nCM020348.1.\nAssembly name: bCatUst1.pri.v2\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the Vertebrate Genomes Project on\n2020/12/22. The original whole-genome shotgun project has the\naccession WNMQ00000000.2.\n\n##Genome-Assembly-Data-START##\nAssembly Provider :: Vertebrate Genomes Project\nAssembly Date :: 06-AUG-2020\nAssembly Method :: FALCON v. DX 1.9.0; FALCON-Unzip v.\n 6.0.0.47841; purge_dups github v.\n purge_haplotig (bitbucket v1.0.3+\n 1.Nov.2018); Scaff10x v. 2; Bionano Solve\n v. 3.2.1_04122018; Salsa2 HiC v. 2.2;\n Arrow polishing and gap filling v.\n Smrtlink_6.0.0.47841; Longranger Align v.\n 2.2.2; freebayes v. 1.3.1; gEVAL manual\n curation v. 2020-08-06; VGP assembly\n pipeline v. 1.5\nAssembly Name :: bCatUst1.pri.v2\nDiploid :: Principal pseudohaplotype\nGenome Representation :: Full\nExpected Final Version :: No\nGenome Coverage :: 60.58x\nSequencing Technology :: PacBio Sequel I CLR; Illumina NovaSeq;\n Arima Genomics Hi-C; Bionano Genomics DLS\n##Genome-Assembly-Data-END##\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Catharus ustulatus Annotation\n Release 101\nAnnotation Version :: 101\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
FYVE, RhoGEF and PH domain containing 5, transcript variant X2
COORDINATES: polyA evidence [ECO:0006239]
FYVE, RhoGEF and PH domain containing 5, transcript variant X1
FYVE, RhoGEF and PH domain-containing protein 5 isoform X1
FYVE, RhoGEF and PH domain-containing protein 5 isoform X2
nuclear receptor subfamily 2 group C member 2, transcript variant X4
nuclear receptor subfamily 2 group C member 2, transcript variant X1
nuclear receptor subfamily 2 group C member 2, transcript variant X2
nuclear receptor subfamily 2 group C member 2, transcript variant X3
nuclear receptor subfamily 2 group C member 2
uncharacterized LOC117002446, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
uncharacterized LOC117002446, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
28S ribosomal protein S25, mitochondrial
thyrotropin releasing hormone, transcript variant X3
thyrotropin releasing hormone, transcript variant X4
thyrotropin releasing hormone, transcript variant X5
thyrotropin releasing hormone, transcript variant X6
thyrotropin releasing hormone, transcript variant X2
thyrotropin releasing hormone, transcript variant X1
transmembrane and coiled-coil domain family 1, transcript variant X2
transmembrane and coiled-coil domain family 1, transcript variant X7
transmembrane and coiled-coil domains protein 1 isoform X7
transmembrane and coiled-coil domain family 1, transcript variant X1
transmembrane and coiled-coil domains protein 1 isoform X1
transmembrane and coiled-coil domains protein 1 isoform X2
transmembrane and coiled-coil domain family 1, transcript variant X4
transmembrane and coiled-coil domains protein 1 isoform X4
transmembrane and coiled-coil domain family 1, transcript variant X6
transmembrane and coiled-coil domains protein 1 isoform X6
transmembrane and coiled-coil domain family 1, transcript variant X3
transmembrane and coiled-coil domains protein 1 isoform X3
transmembrane and coiled-coil domain family 1, transcript variant X5
transmembrane and coiled-coil domains protein 1 isoform X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
intraflagellar transport 122, transcript variant X2
intraflagellar transport 122, transcript variant X1
intraflagellar transport protein 122 homolog isoform X2
intraflagellar transport protein 122 homolog isoform X1
methyl-CpG binding domain 4, DNA glycosylase
Derived by automated computational analysis using gene prediction method: cmsearch.
COORDINATES: nucleotide motif:Rfam:12.0:RF00409
cullin-associated NEDD8-dissociated protein 1-like
SEC13 homolog, nuclear pore and COPII coat complex component
interleukin 1 receptor associated kinase 2
interleukin-1 receptor-associated kinase-like 2
von Hippel-Lindau disease tumor suppressor
THUMP domain containing 3, transcript variant X2
THUMP domain containing 3, transcript variant X1
THUMP domain-containing protein 3 isoform X2
THUMP domain-containing protein 3 isoform X1
SLIT-ROBO Rho GTPase activating protein 3, transcript variant X1
SLIT-ROBO Rho GTPase activating protein 3, transcript variant X2
SLIT-ROBO Rho GTPase-activating protein 3 isoform X1
SLIT-ROBO Rho GTPase-activating protein 3 isoform X2
RAD18 E3 ubiquitin protein ligase, transcript variant X1
RAD18 E3 ubiquitin protein ligase, transcript variant X2
E3 ubiquitin-protein ligase RAD18 isoform X1
E3 ubiquitin-protein ligase RAD18 isoform X2
RAD18 E3 ubiquitin protein ligase, transcript variant X3
E3 ubiquitin-protein ligase RAD18 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 1 EST, 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 22 Proteins
LIM and cysteine rich domains 1, transcript variant X1
LIM and cysteine rich domains 1, transcript variant X2
glutamate metabotropic receptor 7, transcript variant X2
metabotropic glutamate receptor 7 isoform X2
glutamate metabotropic receptor 7, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
metabotropic glutamate receptor 7 isoform X1
ER degradation enhancing alpha-mannosidase like protein 1
ER degradation-enhancing alpha-mannosidase-like protein 1
basic helix-loop-helix family member e40
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: class E basic helix-loop-helix protein 40
inositol 1,4,5-trisphosphate receptor type 1, transcript variant X5
inositol 1,4,5-trisphosphate receptor type 1, transcript variant X10
inositol 1,4,5-trisphosphate receptor type 1, transcript variant X9
inositol 1,4,5-trisphosphate receptor type 1, transcript variant X3
inositol 1,4,5-trisphosphate receptor type 1, transcript variant X4
inositol 1,4,5-trisphosphate receptor type 1, transcript variant X7
inositol 1,4,5-trisphosphate receptor type 1, transcript variant X2
inositol 1,4,5-trisphosphate receptor type 1, transcript variant X1
inositol 1,4,5-trisphosphate receptor type 1, transcript variant X6
inositol 1,4,5-trisphosphate receptor type 1, transcript variant X8
inositol 1,4,5-trisphosphate receptor type 1 isoform X8
inositol 1,4,5-trisphosphate receptor type 1 isoform X7
inositol 1,4,5-trisphosphate receptor type 1 isoform X3
inositol 1,4,5-trisphosphate receptor type 1 isoform X4
inositol 1,4,5-trisphosphate receptor type 1 isoform X5
inositol 1,4,5-trisphosphate receptor type 1 isoform X2
inositol 1,4,5-trisphosphate receptor type 1 isoform X1
inositol 1,4,5-trisphosphate receptor type 1 isoform X6
sulfatase modifying factor 1, transcript variant X2
formylglycine-generating enzyme isoform X2
sulfatase modifying factor 1, transcript variant X1
formylglycine-generating enzyme isoform X1
histone-lysine N-methyltransferase SETMAR
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: leucine-rich repeat neuronal protein 1
uncharacterized LOC117002368, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized LOC117002368, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
CCA tRNA nucleotidyltransferase 1, mitochondrial
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 71% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 2 codons
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
cell adhesion molecule L1 like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 1 EST, 57 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
neural cell adhesion molecule L1-like protein isoform X2
cell adhesion molecule L1 like, transcript variant X4
cell adhesion molecule L1 like, transcript variant X6
cell adhesion molecule L1 like, transcript variant X1
cell adhesion molecule L1 like, transcript variant X3
cell adhesion molecule L1 like, transcript variant X5
neural cell adhesion molecule L1-like protein isoform X3
neural cell adhesion molecule L1-like protein isoform X4
neural cell adhesion molecule L1-like protein isoform X1
cell adhesion molecule L1 like, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 1 EST, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
cell adhesion molecule L1 like, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 1 EST, 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
neural cell adhesion molecule L1-like protein isoform X6
neural cell adhesion molecule L1-like protein isoform X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
PDZ domain containing ring finger 3, transcript variant X1
E3 ubiquitin-protein ligase PDZRN3 isoform X1
PDZ domain containing ring finger 3, transcript variant X2
E3 ubiquitin-protein ligase PDZRN3 isoform X2
protein phosphatase 4 regulatory subunit 2
serine/threonine-protein phosphatase 4 regulatory subunit 2
SHQ1, H/ACA ribonucleoprotein assembly factor, transcript variant X1
SHQ1, H/ACA ribonucleoprotein assembly factor, transcript variant X2
RING1 and YY1 binding protein, transcript variant X2
RING1 and YY1-binding protein isoform X2
RING1 and YY1 binding protein, transcript variant X1
RING1 and YY1-binding protein isoform X1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 84% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: probable G-protein coupled receptor 27
eukaryotic translation initiation factor 4E family member 3, transcript variant X1
eukaryotic translation initiation factor 4E type 3 isoform X1
eukaryotic translation initiation factor 4E family member 3, transcript variant X2
eukaryotic translation initiation factor 4E type 3 isoform X2
MyoD family inhibitor domain containing 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
myoD family inhibitor domain-containing protein 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 24% coverage of the annotated genomic feature by RNAseq alignments
melanocyte inducing transcription factor, transcript variant X2
melanocyte inducing transcription factor, transcript variant X1
microphthalmia-associated transcription factor isoform X2
microphthalmia-associated transcription factor isoform X1
FERM domain containing 4B, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 ESTs, 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
FERM domain containing 4B, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 ESTs, 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
FERM domain-containing protein 4B isoform X1
FERM domain-containing protein 4B isoform X2
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 5 bases in 4 codons; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 23% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 5 bases in 4 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
NEDD8-activating enzyme E1 catalytic subunit-like
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon
LOW QUALITY PROTEIN: NEDD8-activating enzyme E1 catalytic subunit-like
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 ESTs, 3 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: TATA element modulatory factor-like
EGF domain specific O-linked N-acetylglucosamine transferase, transcript variant X1
EGF domain specific O-linked N-acetylglucosamine transferase, transcript variant X2
EGF domain-specific O-linked N-acetylglucosamine transferase isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 39% coverage of the annotated genomic feature by RNAseq alignments
ADP ribosylation factor like GTPase 6 interacting protein 5
NEDD8-activating enzyme E1 catalytic subunit, transcript variant X1
NEDD8-activating enzyme E1 catalytic subunit, transcript variant X3
NEDD8-activating enzyme E1 catalytic subunit, transcript variant X2
NEDD8-activating enzyme E1 catalytic subunit, transcript variant X5
NEDD8-activating enzyme E1 catalytic subunit, transcript variant X4
NEDD8-activating enzyme E1 catalytic subunit isoform X1
NEDD8-activating enzyme E1 catalytic subunit isoform X2
NEDD8-activating enzyme E1 catalytic subunit isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 ESTs, 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
EGF domain specific O-linked N-acetylglucosamine transferase, transcript variant X3
EGF domain-specific O-linked N-acetylglucosamine transferase isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 53% coverage of the annotated genomic feature by RNAseq alignments
TAFA chemokine like family member 4, transcript variant X1
TAFA chemokine like family member 4, transcript variant X3
TAFA chemokine like family member 4, transcript variant X2
succinate-CoA ligase GDP-forming subunit beta
succinate--CoA ligase [GDP-forming] subunit beta, mitochondrial
monocarboxylate transporter 2-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
monocarboxylate transporter 2-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
monocarboxylate transporter 2-like isoform X1
monocarboxylate transporter 2-like isoform X2
kelch repeat and BTB domain containing 8
kelch repeat and BTB domain-containing protein 8
leucine rich repeats and immunoglobulin like domains 1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 ESTs, 17 Proteins, and 89% coverage of the annotated genomic feature by RNAseq alignments
LOW QUALITY PROTEIN: leucine-rich repeats and immunoglobulin-like domains protein 1
S-adenosylmethionine mitochondrial carrier protein
membrane-associated guanylate kinase, WW and PDZ domain-containing protein 1-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 9 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
membrane-associated guanylate kinase, WW and PDZ domain-containing protein 1-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 2 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
membrane-associated guanylate kinase, WW and PDZ domain-containing protein 1-like, transcript variant X3
membrane-associated guanylate kinase, WW and PDZ domain-containing protein 1-like, transcript variant X1
membrane-associated guanylate kinase, WW and PDZ domain-containing protein 1-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 10 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
membrane-associated guanylate kinase, WW and PDZ domain-containing protein 1-like, transcript variant X2
membrane-associated guanylate kinase, WW and PDZ domain-containing protein 1-like isoform X1
membrane-associated guanylate kinase, WW and PDZ domain-containing protein 1-like isoform X5
membrane-associated guanylate kinase, WW and PDZ domain-containing protein 1-like isoform X2
membrane-associated guanylate kinase, WW and PDZ domain-containing protein 1-like isoform X4
membrane-associated guanylate kinase, WW and PDZ domain-containing protein 1-like isoform X6
membrane-associated guanylate kinase, WW and PDZ domain-containing protein 1-like isoform X3
membrane associated guanylate kinase, WW and PDZ domain containing 1, transcript variant X20
membrane-associated guanylate kinase, WW and PDZ domain-containing protein 1 isoform X20
membrane associated guanylate kinase, WW and PDZ domain containing 1, transcript variant X1
membrane associated guanylate kinase, WW and PDZ domain containing 1, transcript variant X4
membrane associated guanylate kinase, WW and PDZ domain containing 1, transcript variant X5
membrane associated guanylate kinase, WW and PDZ domain containing 1, transcript variant X6
membrane associated guanylate kinase, WW and PDZ domain containing 1, transcript variant X8
membrane associated guanylate kinase, WW and PDZ domain containing 1, transcript variant X10
membrane associated guanylate kinase, WW and PDZ domain containing 1, transcript variant X14
membrane associated guanylate kinase, WW and PDZ domain containing 1, transcript variant X11
membrane associated guanylate kinase, WW and PDZ domain containing 1, transcript variant X12
membrane associated guanylate kinase, WW and PDZ domain containing 1, transcript variant X13
membrane associated guanylate kinase, WW and PDZ domain containing 1, transcript variant X2
membrane associated guanylate kinase, WW and PDZ domain containing 1, transcript variant X21
membrane associated guanylate kinase, WW and PDZ domain containing 1, transcript variant X9
membrane associated guanylate kinase, WW and PDZ domain containing 1, transcript variant X18
membrane associated guanylate kinase, WW and PDZ domain containing 1, transcript variant X15
membrane associated guanylate kinase, WW and PDZ domain containing 1, transcript variant X17
membrane associated guanylate kinase, WW and PDZ domain containing 1, transcript variant X19
membrane associated guanylate kinase, WW and PDZ domain containing 1, transcript variant X3
membrane associated guanylate kinase, WW and PDZ domain containing 1, transcript variant X16
membrane-associated guanylate kinase, WW and PDZ domain-containing protein 1 isoform X1
membrane-associated guanylate kinase, WW and PDZ domain-containing protein 1 isoform X4
membrane-associated guanylate kinase, WW and PDZ domain-containing protein 1 isoform X5
membrane-associated guanylate kinase, WW and PDZ domain-containing protein 1 isoform X6
membrane-associated guanylate kinase, WW and PDZ domain-containing protein 1 isoform X8
membrane-associated guanylate kinase, WW and PDZ domain-containing protein 1 isoform X10
membrane-associated guanylate kinase, WW and PDZ domain-containing protein 1 isoform X14
membrane-associated guanylate kinase, WW and PDZ domain-containing protein 1 isoform X11
membrane-associated guanylate kinase, WW and PDZ domain-containing protein 1 isoform X12
membrane-associated guanylate kinase, WW and PDZ domain-containing protein 1 isoform X13
membrane-associated guanylate kinase, WW and PDZ domain-containing protein 1 isoform X2
membrane-associated guanylate kinase, WW and PDZ domain-containing protein 1 isoform X21
membrane-associated guanylate kinase, WW and PDZ domain-containing protein 1 isoform X9
membrane-associated guanylate kinase, WW and PDZ domain-containing protein 1 isoform X18
membrane-associated guanylate kinase, WW and PDZ domain-containing protein 1 isoform X15
membrane-associated guanylate kinase, WW and PDZ domain-containing protein 1 isoform X17
membrane-associated guanylate kinase, WW and PDZ domain-containing protein 1 isoform X19
membrane-associated guanylate kinase, WW and PDZ domain-containing protein 1 isoform X3
membrane-associated guanylate kinase, WW and PDZ domain-containing protein 1 isoform X16
membrane associated guanylate kinase, WW and PDZ domain containing 1, transcript variant X7
membrane associated guanylate kinase, WW and PDZ domain containing 1, transcript variant X22
membrane-associated guanylate kinase, WW and PDZ domain-containing protein 1 isoform X7
membrane-associated guanylate kinase, WW and PDZ domain-containing protein 1 isoform X22
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
uncharacterized LOC117002413, transcript variant X1
uncharacterized LOC117002413, transcript variant X2
ADAM metallopeptidase with thrombospondin type 1 motif 9, transcript variant X5
ADAM metallopeptidase with thrombospondin type 1 motif 9, transcript variant X1
ADAM metallopeptidase with thrombospondin type 1 motif 9, transcript variant X2
ADAM metallopeptidase with thrombospondin type 1 motif 9, transcript variant X3
ADAM metallopeptidase with thrombospondin type 1 motif 9, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
A disintegrin and metalloproteinase with thrombospondin motifs 9 isoform X1
A disintegrin and metalloproteinase with thrombospondin motifs 9 isoform X2
A disintegrin and metalloproteinase with thrombospondin motifs 9 isoform X5
A disintegrin and metalloproteinase with thrombospondin motifs 9 isoform X3
A disintegrin and metalloproteinase with thrombospondin motifs 9 isoform X4
ADAM metallopeptidase with thrombospondin type 1 motif 9, transcript variant X6
A disintegrin and metalloproteinase with thrombospondin motifs 9 isoform X6
prickle planar cell polarity protein 2, transcript variant X1
prickle planar cell polarity protein 2, transcript variant X3
prickle planar cell polarity protein 2, transcript variant X2
26S proteasome non-ATPase regulatory subunit 6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
calcium dependent secretion activator, transcript variant X1
calcium dependent secretion activator, transcript variant X4
calcium dependent secretion activator, transcript variant X12
calcium dependent secretion activator, transcript variant X14
calcium dependent secretion activator, transcript variant X2
calcium dependent secretion activator, transcript variant X13
calcium dependent secretion activator, transcript variant X15
calcium dependent secretion activator, transcript variant X5
calcium dependent secretion activator, transcript variant X7
calcium dependent secretion activator, transcript variant X9
calcium dependent secretion activator, transcript variant X3
calcium dependent secretion activator, transcript variant X17
calcium dependent secretion activator, transcript variant X18
calcium dependent secretion activator, transcript variant X6
calcium dependent secretion activator, transcript variant X16
calcium dependent secretion activator, transcript variant X8
calcium dependent secretion activator, transcript variant X10
calcium dependent secretion activator, transcript variant X11
calcium-dependent secretion activator 1 isoform X1
calcium-dependent secretion activator 1 isoform X4
calcium-dependent secretion activator 1 isoform X12
calcium-dependent secretion activator 1 isoform X14
calcium-dependent secretion activator 1 isoform X2
calcium-dependent secretion activator 1 isoform X13
calcium-dependent secretion activator 1 isoform X15
calcium-dependent secretion activator 1 isoform X5
calcium-dependent secretion activator 1 isoform X7
calcium-dependent secretion activator 1 isoform X9
calcium-dependent secretion activator 1 isoform X3
calcium-dependent secretion activator 1 isoform X17
calcium-dependent secretion activator 1 isoform X18
calcium-dependent secretion activator 1 isoform X6
calcium-dependent secretion activator 1 isoform X16
calcium-dependent secretion activator 1 isoform X8
calcium-dependent secretion activator 1 isoform X10
calcium-dependent secretion activator 1 isoform X11
protein tyrosine phosphatase receptor type G
receptor-type tyrosine-protein phosphatase gamma
fragile histidine triad diadenosine triphosphatase, transcript variant X1
bis(5'-adenosyl)-triphosphatase isoform X1
fragile histidine triad diadenosine triphosphatase, transcript variant X2
bis(5'-adenosyl)-triphosphatase isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 19% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 63% coverage of the annotated genomic feature by RNAseq alignments
FAM3 metabolism regulating signaling molecule D, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
FAM3 metabolism regulating signaling molecule D, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
FAM3 metabolism regulating signaling molecule D, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
FAM3 metabolism regulating signaling molecule D, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
family with sequence similarity 107 member A, transcript variant X1
actin-associated protein FAM107A isoform X1
family with sequence similarity 107 member A, transcript variant X2
actin-associated protein FAM107A isoform X2
LOW QUALITY PROTEIN: peroxisomal acyl-coenzyme A oxidase 2
potassium channel tetramerization domain containing 6, transcript variant X1
potassium channel tetramerization domain containing 6, transcript variant X2
potassium channel tetramerization domain containing 6, transcript variant X3
pyruvate dehydrogenase E1 component subunit beta, mitochondrial
PX domain containing serine/threonine kinase like, transcript variant X1
PX domain containing serine/threonine kinase like, transcript variant X2
PX domain-containing protein kinase-like protein isoform X2
PX domain-containing protein kinase-like protein isoform X1
PX domain containing serine/threonine kinase like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 ESTs, 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
PX domain containing serine/threonine kinase like, transcript variant X9
PX domain containing serine/threonine kinase like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 ESTs, 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
PX domain containing serine/threonine kinase like, transcript variant X7
PX domain containing serine/threonine kinase like, transcript variant X4
PX domain containing serine/threonine kinase like, transcript variant X8
PX domain-containing protein kinase-like protein isoform X4
PX domain-containing protein kinase-like protein isoform X3
PX domain-containing protein kinase-like protein isoform X7
PX domain-containing protein kinase-like protein isoform X6
PX domain containing serine/threonine kinase like, transcript variant X6
PX domain-containing protein kinase-like protein isoform X5
hydroxyacyl-thioester dehydratase type 2
hydroxyacyl-thioester dehydratase type 2, mitochondrial
protein kinase cAMP-dependent type II regulatory subunit alpha
cAMP-dependent protein kinase type II-alpha regulatory subunit
mitochondrial carnitine/acylcarnitine carrier protein
ariadne RBR E3 ubiquitin protein ligase 2, transcript variant X2
ariadne RBR E3 ubiquitin protein ligase 2, transcript variant X1
ariadne RBR E3 ubiquitin protein ligase 2, transcript variant X3
E3 ubiquitin-protein ligase ARIH2 isoform X1
ariadne RBR E3 ubiquitin protein ligase 2, transcript variant X4
E3 ubiquitin-protein ligase ARIH2 isoform X2
secreted frizzled-related protein 5-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
secreted frizzled-related protein 5-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
secreted frizzled-related protein 5-like isoform X2
secreted frizzled-related protein 5-like isoform X1
DALR anticodon binding domain containing 3
DALR anticodon-binding domain-containing protein 3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 mRNAs, and 100% coverage of the annotated genomic feature by RNAseq alignments
NADH:ubiquinone oxidoreductase complex assembly factor 3, transcript variant X2
NADH:ubiquinone oxidoreductase complex assembly factor 3, transcript variant X1
NADH dehydrogenase [ubiquinone] 1 alpha subcomplex assembly factor 3 isoform X1
NADH dehydrogenase [ubiquinone] 1 alpha subcomplex assembly factor 3 isoform X2
inosine-5'-monophosphate dehydrogenase 2
epidermal differentiation-specific protein-like
solute carrier family 6 member 8, transcript variant X2
solute carrier family 6 member 8, transcript variant X1
solute carrier family 6 member 8, transcript variant X3
sodium- and chloride-dependent creatine transporter 1 isoform X2
sodium- and chloride-dependent creatine transporter 1 isoform X1
ubiquitin specific peptidase 19, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 ESTs, 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
ubiquitin specific peptidase 19, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 ESTs, 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
ubiquitin carboxyl-terminal hydrolase 19 isoform X7
ubiquitin carboxyl-terminal hydrolase 19 isoform X6
ubiquitin specific peptidase 19, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 ESTs, 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
ubiquitin specific peptidase 19, transcript variant X7
ubiquitin specific peptidase 19, transcript variant X6
ubiquitin specific peptidase 19, transcript variant X4
ubiquitin specific peptidase 19, transcript variant X5
ubiquitin specific peptidase 19, transcript variant X1
ubiquitin specific peptidase 19, transcript variant X3
ubiquitin carboxyl-terminal hydrolase 19 isoform X5
ubiquitin carboxyl-terminal hydrolase 19 isoform X4
ubiquitin carboxyl-terminal hydrolase 19 isoform X2
ubiquitin carboxyl-terminal hydrolase 19 isoform X3
ubiquitin carboxyl-terminal hydrolase 19 isoform X1
laminin subunit beta-2-like, transcript variant X1
laminin subunit beta-2-like, transcript variant X2
laminin subunit beta-2-like, transcript variant X4
laminin subunit beta-2-like, transcript variant X5
laminin subunit beta-2-like, transcript variant X6
laminin subunit beta-2-like, transcript variant X3
coiled-coil domain-containing protein 71
uncharacterized LOC117002352, transcript variant X1
uncharacterized LOC117002352, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
uncharacterized protein LOC117002352 isoform X1
uncharacterized protein LOC117002352 isoform X2
kelch domain containing 8B, transcript variant X2
kelch domain-containing protein 8B isoform X2
kelch domain containing 8B, transcript variant X1
kelch domain-containing protein 8B isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 76% coverage of the annotated genomic feature by RNAseq alignments
proline rich transmembrane protein 3, transcript variant X1
proline rich transmembrane protein 3, transcript variant X2
cysteine rich with EGF like domains 1, transcript variant X2
cysteine rich with EGF like domains 1, transcript variant X1
protein disulfide isomerase CRELD1 isoform X2
protein disulfide isomerase CRELD1 isoform X1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 3 bases in 2 codons
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 3 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: interleukin-17 receptor C
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 92% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
RNA pseudouridine synthase D3, transcript variant X1
mitochondrial mRNA pseudouridine synthase RPUSD3 isoform X1
RNA pseudouridine synthase D3, transcript variant X2
mitochondrial mRNA pseudouridine synthase RPUSD3 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 5 ESTs, 29 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
transcriptional adaptor 3, transcript variant X1
transcriptional adaptor 3, transcript variant X2
calcium/calmodulin dependent protein kinase I
calcium/calmodulin-dependent protein kinase type 1
8-oxoguanine DNA glycosylase, transcript variant X2
8-oxoguanine DNA glycosylase, transcript variant X1
bromodomain and PHD finger containing 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 ESTs, 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
bromodomain and PHD finger containing 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 11 ESTs, 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
myotubularin related protein 14, transcript variant X1
myotubularin related protein 14, transcript variant X2
myotubularin-related protein 14 isoform X2
myotubularin-related protein 14 isoform X1
LHFPL tetraspan subfamily member 4 protein
SET domain containing 5, transcript variant X1
SET domain containing 5, transcript variant X2
histone-lysine N-methyltransferase SETD5 isoform X1
histone-lysine N-methyltransferase SETD5 isoform X2
SRSF protein kinase 3-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
SRSF protein kinase 3-like, transcript variant X1
coiled-coil domain containing 51, transcript variant X2
coiled-coil domain containing 51, transcript variant X3
coiled-coil domain containing 51, transcript variant X4
coiled-coil domain containing 51, transcript variant X1
coiled-coil domain containing 174, transcript variant X2
coiled-coil domain containing 174, transcript variant X1
coiled-coil domain-containing protein 174 isoform X2
coiled-coil domain-containing protein 174 isoform X1
glutamate receptor interacting protein 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 1 EST, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
glutamate receptor-interacting protein 2 isoform X3
glutamate receptor interacting protein 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 1 EST, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
glutamate receptor interacting protein 2, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
glutamate receptor-interacting protein 2 isoform X1
glutamate receptor-interacting protein 2 isoform X7
glutamate receptor interacting protein 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 1 EST, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
glutamate receptor-interacting protein 2 isoform X4
glutamate receptor interacting protein 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 1 EST, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
glutamate receptor-interacting protein 2 isoform X2
glutamate receptor interacting protein 2, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 1 EST, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
glutamate receptor interacting protein 2, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 1 EST, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
glutamate receptor-interacting protein 2 isoform X5
glutamate receptor-interacting protein 2 isoform X6
solute carrier family 6 member 6, transcript variant X7
solute carrier family 6 member 6, transcript variant X5
solute carrier family 6 member 6, transcript variant X6
solute carrier family 6 member 6, transcript variant X8
solute carrier family 6 member 6, transcript variant X3
solute carrier family 6 member 6, transcript variant X4
solute carrier family 6 member 6, transcript variant X2
solute carrier family 6 member 6, transcript variant X1
sodium- and chloride-dependent taurine transporter isoform X2
sodium- and chloride-dependent taurine transporter isoform X1
sodium- and chloride-dependent taurine transporter isoform X4
sodium- and chloride-dependent taurine transporter isoform X3
LSM3 homolog, U6 small nuclear RNA and mRNA degradation associated
U6 snRNA-associated Sm-like protein LSm3
XPC complex subunit, DNA damage recognition and repair factor, transcript variant X1
XPC complex subunit, DNA damage recognition and repair factor, transcript variant X2
XPC complex subunit, DNA damage recognition and repair factor, transcript variant X3
DNA repair protein complementing XP-C cells isoform X1
DNA repair protein complementing XP-C cells isoform X2
DNA repair protein complementing XP-C cells isoform X3
coiled-coil-helix-coiled-coil-helix domain containing 4
mitochondrial intermembrane space import and assembly protein 40
cilia and flagella associated protein 100, transcript variant X2
cilia- and flagella-associated protein 100 isoform X2
cilia and flagella associated protein 100, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
cilia and flagella associated protein 100, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
cilia- and flagella-associated protein 100 isoform X3
cilia- and flagella-associated protein 100 isoform X1
Kruppel like factor 15, transcript variant X2
Kruppel like factor 15, transcript variant X1
solute carrier family 41 member 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 ESTs, 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
solute carrier family 41 member 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 ESTs, 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
solute carrier family 41 member 3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 ESTs, 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
solute carrier family 41 member 3 isoform X1
solute carrier family 41 member 3, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 ESTs, 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
solute carrier family 41 member 3 isoform X2
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA leucine (anticodon UAA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
coiled-coil-helix-coiled-coil-helix domain containing 6, transcript variant X2
coiled-coil-helix-coiled-coil-helix domain containing 6, transcript variant X1
transmembrane protein adipocyte associated 1, transcript variant X1
transmembrane protein adipocyte associated 1, transcript variant X3
transmembrane protein adipocyte associated 1, transcript variant X2
transmembrane protein adipocyte-associated 1
minichromosome maintenance complex component 2
ankyrin repeat and BTB domain containing 1
ankyrin repeat and BTB/POZ domain-containing protein 1
monoglyceride lipase, transcript variant X2
monoglyceride lipase, transcript variant X1
kelch repeat and BTB domain containing 12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 59% coverage of the annotated genomic feature by RNAseq alignments
kelch repeat and BTB domain-containing protein 12
protein transport protein Sec61 subunit alpha
eukaryotic elongation factor, selenocysteine-tRNA specific, transcript variant X2
eukaryotic elongation factor, selenocysteine-tRNA specific, transcript variant X1
selenocysteine-specific elongation factor isoform X1
selenocysteine-specific elongation factor isoform X2
DnaJ heat shock protein family (Hsp40) member B8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 3 Proteins
GATA binding protein 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 11 ESTs, 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
GATA binding protein 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 11 ESTs, 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 ESTs, 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
5-hydroxymethylcytosine binding, ES cell specific
cytochrome b-c1 complex subunit 1, mitochondrial
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
cadherin EGF LAG seven-pass G-type receptor 3
inositol hexakisphosphate kinase 2, transcript variant X1
inositol hexakisphosphate kinase 2, transcript variant X2
abhydrolase domain containing 6, acylglycerol lipase, transcript variant X1
abhydrolase domain containing 6, acylglycerol lipase, transcript variant X3
abhydrolase domain containing 6, acylglycerol lipase, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 8 Proteins, and 86% coverage of the annotated genomic feature by RNAseq alignments
sarcolemma associated protein, transcript variant X3
sarcolemmal membrane-associated protein isoform X3
sarcolemma associated protein, transcript variant X20
sarcolemma associated protein, transcript variant X14
sarcolemma associated protein, transcript variant X17
sarcolemma associated protein, transcript variant X9
sarcolemma associated protein, transcript variant X4
sarcolemma associated protein, transcript variant X16
sarcolemma associated protein, transcript variant X8
sarcolemma associated protein, transcript variant X11
sarcolemma associated protein, transcript variant X6
sarcolemma associated protein, transcript variant X12
sarcolemma associated protein, transcript variant X1
sarcolemma associated protein, transcript variant X23
sarcolemmal membrane-associated protein isoform X20
sarcolemmal membrane-associated protein isoform X14
sarcolemmal membrane-associated protein isoform X17
sarcolemmal membrane-associated protein isoform X9
sarcolemmal membrane-associated protein isoform X4
sarcolemmal membrane-associated protein isoform X16
sarcolemmal membrane-associated protein isoform X8
sarcolemmal membrane-associated protein isoform X11
sarcolemmal membrane-associated protein isoform X6
sarcolemmal membrane-associated protein isoform X12
sarcolemmal membrane-associated protein isoform X1
sarcolemmal membrane-associated protein isoform X23
sarcolemma associated protein, transcript variant X22
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 ESTs, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
sarcolemma associated protein, transcript variant X15
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 ESTs, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
sarcolemma associated protein, transcript variant X18
sarcolemma associated protein, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 ESTs, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
sarcolemma associated protein, transcript variant X21
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 ESTs, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
sarcolemma associated protein, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 ESTs, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
sarcolemma associated protein, transcript variant X19
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 7 ESTs, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
sarcolemma associated protein, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 8 ESTs, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
sarcolemma associated protein, transcript variant X13
sarcolemma associated protein, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 8 ESTs, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
sarcolemmal membrane-associated protein isoform X22
sarcolemmal membrane-associated protein isoform X15
sarcolemmal membrane-associated protein isoform X18
sarcolemmal membrane-associated protein isoform X5
sarcolemmal membrane-associated protein isoform X21
sarcolemmal membrane-associated protein isoform X10
sarcolemmal membrane-associated protein isoform X19
sarcolemmal membrane-associated protein isoform X7
sarcolemmal membrane-associated protein isoform X13
sarcolemmal membrane-associated protein isoform X2
DENN domain containing 6A, transcript variant X1
DENN domain containing 6A, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 2 ESTs, 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
ankyrin repeat and SOCS box containing 14, transcript variant X1
ankyrin repeat and SOCS box protein 14 isoform X1
ankyrin repeat and SOCS box containing 14, transcript variant X2
ankyrin repeat and SOCS box protein 14 isoform X2
adaptor protein, phosphotyrosine interacting with PH domain and leucine zipper 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 8 Proteins, and 86% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Rho guanine nucleotide exchange factor 3
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 4 bases in 3 codons; deleted 4 bases in 2 codons
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 4 bases in 3 codons; deleted 4 bases in 2 codons; substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: rho guanine nucleotide exchange factor 3
transcription activation suppressor, transcript variant X1
transcription activation suppressor, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
coiled-coil domain containing 66, transcript variant X3
coiled-coil domain containing 66, transcript variant X2
coiled-coil domain containing 66, transcript variant X1
coiled-coil domain-containing protein 66 isoform X2
coiled-coil domain-containing protein 66 isoform X1
coiled-coil domain-containing protein 66 isoform X3
ELKS/RAB6-interacting/CAST family member 2, transcript variant X2
ELKS/RAB6-interacting/CAST family member 2, transcript variant X3
ELKS/RAB6-interacting/CAST family member 2, transcript variant X4
ELKS/RAB6-interacting/CAST family member 2, transcript variant X9
ELKS/RAB6-interacting/CAST family member 2, transcript variant X1
ELKS/RAB6-interacting/CAST family member 2, transcript variant X6
ELKS/RAB6-interacting/CAST family member 2, transcript variant X8
ELKS/RAB6-interacting/CAST family member 2, transcript variant X11
ELKS/RAB6-interacting/CAST family member 2, transcript variant X5
ELKS/RAB6-interacting/CAST family member 2, transcript variant X7
ELKS/RAB6-interacting/CAST family member 2, transcript variant X10
Wnt family member 5A, transcript variant X1
Wnt family member 5A, transcript variant X5
Wnt family member 5A, transcript variant X3
Wnt family member 5A, transcript variant X2
Wnt family member 5A, transcript variant X4
calcium voltage-gated channel auxiliary subunit alpha2delta 3, transcript variant X2
calcium voltage-gated channel auxiliary subunit alpha2delta 3, transcript variant X1
voltage-dependent calcium channel subunit alpha-2/delta-3 isoform X2
voltage-dependent calcium channel subunit alpha-2/delta-3 isoform X1
calcium voltage-gated channel auxiliary subunit alpha2delta 3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
leucine rich repeats and transmembrane domains 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins
leucine-rich repeat and transmembrane domain-containing protein 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
choline dehydrogenase, transcript variant X2
choline dehydrogenase, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
calcium voltage-gated channel subunit alpha1 D, transcript variant X3
calcium voltage-gated channel subunit alpha1 D, transcript variant X5
calcium voltage-gated channel subunit alpha1 D, transcript variant X10
calcium voltage-gated channel subunit alpha1 D, transcript variant X7
calcium voltage-gated channel subunit alpha1 D, transcript variant X4
calcium voltage-gated channel subunit alpha1 D, transcript variant X1
calcium voltage-gated channel subunit alpha1 D, transcript variant X12
calcium voltage-gated channel subunit alpha1 D, transcript variant X9
calcium voltage-gated channel subunit alpha1 D, transcript variant X6
calcium voltage-gated channel subunit alpha1 D, transcript variant X11
calcium voltage-gated channel subunit alpha1 D, transcript variant X8
calcium voltage-gated channel subunit alpha1 D, transcript variant X2
calcium voltage-gated channel subunit alpha1 D, transcript variant X15
calcium voltage-gated channel subunit alpha1 D, transcript variant X13
calcium voltage-gated channel subunit alpha1 D, transcript variant X14
voltage-dependent L-type calcium channel subunit alpha-1D isoform X3
voltage-dependent L-type calcium channel subunit alpha-1D isoform X5
voltage-dependent L-type calcium channel subunit alpha-1D isoform X10
voltage-dependent L-type calcium channel subunit alpha-1D isoform X7
voltage-dependent L-type calcium channel subunit alpha-1D isoform X4
voltage-dependent L-type calcium channel subunit alpha-1D isoform X1
voltage-dependent L-type calcium channel subunit alpha-1D isoform X12
voltage-dependent L-type calcium channel subunit alpha-1D isoform X9
voltage-dependent L-type calcium channel subunit alpha-1D isoform X6
voltage-dependent L-type calcium channel subunit alpha-1D isoform X11
voltage-dependent L-type calcium channel subunit alpha-1D isoform X8
voltage-dependent L-type calcium channel subunit alpha-1D isoform X2
voltage-dependent L-type calcium channel subunit alpha-1D isoform X15
voltage-dependent L-type calcium channel subunit alpha-1D isoform X14
voltage-dependent L-type calcium channel subunit alpha-1D isoform X13
transmembrane protein 40, transcript variant X1
transmembrane protein 40, transcript variant X2
BRICK1 subunit of SCAR/WAVE actin nucleating complex
ubiquitin specific peptidase 4, transcript variant X1
ubiquitin specific peptidase 4, transcript variant X2
ubiquitin carboxyl-terminal hydrolase 4 isoform X1
ubiquitin carboxyl-terminal hydrolase 4 isoform X2
ras homolog family member A, transcript variant X2
ras homolog family member A, transcript variant X1
testis expressed 264, ER-phagy receptor, transcript variant X2
testis expressed 264, ER-phagy receptor, transcript variant X1
ribosomal RNA processing 9, U3 small nucleolar RNA binding protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
U3 small nucleolar RNA-interacting protein 2
N-alpha-acetyltransferase 80, NatH catalytic subunit
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 2 codons
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 2 codons; substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: N-alpha-acetyltransferase 80
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 31 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
leucine rich single-pass membrane protein 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
leucine-rich single-pass membrane protein 2
interferon related developmental regulator 2
interferon-related developmental regulator 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 49 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 43 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
solute carrier family 38 member 3, transcript variant X2
solute carrier family 38 member 3, transcript variant X3
solute carrier family 38 member 3, transcript variant X1
sodium-coupled neutral amino acid transporter 3 isoform X1
sodium-coupled neutral amino acid transporter 3 isoform X2
guanine nucleotide-binding protein G(i) subunit alpha-2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 107 Proteins, and 85% coverage of the annotated genomic feature by RNAseq alignments
guanine nucleotide-binding protein G(t) subunit alpha-1
protein mono-ADP-ribosyltransferase PARP3-like
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments
LOW QUALITY PROTEIN: protein mono-ADP-ribosyltransferase PARP3-like
protein mono-ADP-ribosyltransferase PARP3-like, transcript variant X2
protein mono-ADP-ribosyltransferase PARP3-like, transcript variant X1
protein mono-ADP-ribosyltransferase PARP3-like, transcript variant X3
protein mono-ADP-ribosyltransferase PARP3-like, transcript variant X4
aminoacylase-1-like, transcript variant X2
aminoacylase-1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 71 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
BRCA1 associated protein 1, transcript variant X1
BRCA1 associated protein 1, transcript variant X2
ubiquitin carboxyl-terminal hydrolase BAP1 isoform X1
ubiquitin carboxyl-terminal hydrolase BAP1 isoform X2
dynein axonemal heavy chain 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 ESTs, 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
dynein axonemal heavy chain 1, transcript variant X1
dynein axonemal heavy chain 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 42% coverage of the annotated genomic feature by RNAseq alignments
protein phosphatase, Mg2+/Mn2+ dependent 1M
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon
5-aminolevulinate synthase, nonspecific, mitochondrial
POC1 centriolar protein A, transcript variant X5
POC1 centriolar protein homolog A isoform X4
POC1 centriolar protein A, transcript variant X1
POC1 centriolar protein A, transcript variant X2
POC1 centriolar protein A, transcript variant X4
POC1 centriolar protein homolog A isoform X1
POC1 centriolar protein homolog A isoform X2
POC1 centriolar protein A, transcript variant X3
POC1 centriolar protein homolog A isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
troponin C1, slow skeletal and cardiac type
troponin C, slow skeletal and cardiac muscles
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 ESTs, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 ESTs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
5'-nucleotidase domain-containing protein 2
small integral membrane protein 4, transcript variant X2
small integral membrane protein 4, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 ESTs, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
guanine nucleotide-binding protein-like 3
COORDINATES: nucleotide motif:Rfam:12.0:RF00569
COORDINATES: nucleotide motif:Rfam:12.0:RF00574
glycosyltransferase 8 domain containing 1, transcript variant X1
glycosyltransferase 8 domain containing 1, transcript variant X2
glycosyltransferase 8 domain containing 1, transcript variant X3
glycosyltransferase 8 domain-containing protein 1
NIMA related kinase 4, transcript variant X2
NIMA related kinase 4, transcript variant X1
serine/threonine-protein kinase Nek4 isoform X2
serine/threonine-protein kinase Nek4 isoform X1
inter-alpha-trypsin inhibitor heavy chain H3-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 51 Proteins, and 85% coverage of the annotated genomic feature by RNAseq alignments
inter-alpha-trypsin inhibitor heavy chain 4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 46 Proteins, and 63% coverage of the annotated genomic feature by RNAseq alignments
inter-alpha-trypsin inhibitor heavy chain H4
musculoskeletal, embryonic nuclear protein 1
musculoskeletal embryonic nuclear protein 1
store-operated calcium entry regulator STIMATE
Scm like with four mbt domains 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Scm like with four mbt domains 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Scm like with four mbt domains 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
scm-like with four MBT domains protein 1
protein kinase C delta, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 ESTs, 33 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
protein kinase C delta, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 ESTs, 33 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
protein kinase C delta, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 ESTs, 34 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
protein kinase C delta, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 ESTs, 33 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatase 4, transcript variant X2
6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatase 4, transcript variant X3
6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatase 4, transcript variant X1
6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatase 4, transcript variant X4
6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatase 4 isoform X2
6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatase 4 isoform X3
6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatase 4 isoform X1
6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatase 4 isoform X4
6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatase 4, transcript variant X6
6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatase 4, transcript variant X5
6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatase 4 isoform X6
6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatase 4 isoform X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 ESTs, 32 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 ESTs, 32 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
tumor suppressor 2, mitochondrial calcium regulator
ras association domain-containing protein 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 ESTs, 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
zinc finger MYND domain-containing protein 10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 ESTs, 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
calcium voltage-gated channel auxiliary subunit alpha2delta 2, transcript variant X2
calcium voltage-gated channel auxiliary subunit alpha2delta 2, transcript variant X1
voltage-dependent calcium channel subunit alpha-2/delta-2 isoform X2
voltage-dependent calcium channel subunit alpha-2/delta-2 isoform X1
chromosome 13 C3orf18 homolog, transcript variant X2
chromosome 13 C3orf18 homolog, transcript variant X1
HemK methyltransferase family member 1, transcript variant X1
HemK methyltransferase family member 1, transcript variant X2
MTRF1L release factor glutamine methyltransferase
cytokine inducible SH2 containing protein
cytokine-inducible SH2-containing protein
MAPK activated protein kinase 3, transcript variant X2
MAPK activated protein kinase 3, transcript variant X1
dedicator of cytokinesis 3, transcript variant X1
dedicator of cytokinesis 3, transcript variant X6
dedicator of cytokinesis 3, transcript variant X3
dedicator of cytokinesis 3, transcript variant X7
dedicator of cytokinesis 3, transcript variant X9
dedicator of cytokinesis 3, transcript variant X8
dedicator of cytokinesis 3, transcript variant X4
dedicator of cytokinesis 3, transcript variant X10
dedicator of cytokinesis 3, transcript variant X5
dedicator of cytokinesis 3, transcript variant X2
dedicator of cytokinesis protein 3 isoform X1
dedicator of cytokinesis protein 3 isoform X6
dedicator of cytokinesis protein 3 isoform X3
dedicator of cytokinesis protein 3 isoform X7
dedicator of cytokinesis protein 3 isoform X9
dedicator of cytokinesis protein 3 isoform X8
dedicator of cytokinesis protein 3 isoform X4
dedicator of cytokinesis protein 3 isoform X10
dedicator of cytokinesis protein 3 isoform X5
dedicator of cytokinesis protein 3 isoform X2
mesencephalic astrocyte derived neurotrophic factor
mesencephalic astrocyte-derived neurotrophic factor
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 36 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
RNA binding motif protein 6, transcript variant X1
RNA binding motif protein 6, transcript variant X2
MON1 homolog A, secretory trafficking associated
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 77% coverage of the annotated genomic feature by RNAseq alignments
caM kinase-like vesicle-associated protein
TRAF interacting protein, transcript variant X2
E3 ubiquitin-protein ligase TRAIP isoform X2
TRAF interacting protein, transcript variant X1
TRAF interacting protein, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
E3 ubiquitin-protein ligase TRAIP isoform X1
E3 ubiquitin-protein ligase TRAIP isoform X3
bassoon presynaptic cytomatrix protein, transcript variant X1
bassoon presynaptic cytomatrix protein, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
macrophage stimulating 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
macrophage stimulating 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
hepatocyte growth factor-like protein isoform X2
hepatocyte growth factor-like protein isoform X1
T-cell leukemia translocation-altered gene protein
ubiquitin like modifier activating enzyme 7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 26 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
ubiquitin-like modifier-activating enzyme 7
cadherin related family member 4, transcript variant X1
cadherin related family member 4, transcript variant X2
cadherin related family member 4, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
cadherin-related family member 4 isoform X1
cadherin-related family member 4 isoform X2
cadherin-related family member 4 isoform X5
cadherin related family member 4, transcript variant X3
cadherin related family member 4, transcript variant X4
cadherin-related family member 4 isoform X3
cadherin-related family member 4 isoform X4
inositol hexakisphosphate kinase 1, transcript variant X1
inositol hexakisphosphate kinase 1, transcript variant X2
inositol hexakisphosphate kinase 1 isoform X1
inositol hexakisphosphate kinase 1 isoform X2
mannose-1-phosphate guanyltransferase beta
ring finger protein 123, transcript variant X4
ring finger protein 123, transcript variant X1
ring finger protein 123, transcript variant X2
ring finger protein 123, transcript variant X3
ring finger protein 123, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 9 ESTs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
ATR interacting protein, transcript variant X2
ATR interacting protein, transcript variant X1
centromere protein P, transcript variant X2
centromere protein P, transcript variant X4
centromere protein P, transcript variant X3
centromere protein P, transcript variant X5
centromere protein P, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 ESTs, 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 82% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
nucleolar protein 8, transcript variant X3
nucleolar protein 8, transcript variant X1
nucleolar protein 8, transcript variant X4
nucleolar protein 8, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 90% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 94% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 61% coverage of the annotated genomic feature by RNAseq alignments
COORDINATES: nucleotide motif:Rfam:12.0:RF01229
ATPase plasma membrane Ca2+ transporting 2, transcript variant X3
ATPase plasma membrane Ca2+ transporting 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
ATPase plasma membrane Ca2+ transporting 2, transcript variant X5
ATPase plasma membrane Ca2+ transporting 2, transcript variant X1
ATPase plasma membrane Ca2+ transporting 2, transcript variant X2
ATPase plasma membrane Ca2+ transporting 2, transcript variant X6
plasma membrane calcium-transporting ATPase 2 isoform X1
plasma membrane calcium-transporting ATPase 2 isoform X2
plasma membrane calcium-transporting ATPase 2 isoform X5
plasma membrane calcium-transporting ATPase 2 isoform X3
plasma membrane calcium-transporting ATPase 2 isoform X4
sodium- and chloride-dependent GABA transporter 3
sodium- and chloride-dependent GABA transporter 1
autophagy related 7, transcript variant X1
ubiquitin-like modifier-activating enzyme ATG7 isoform X1
autophagy related 7, transcript variant X2
ubiquitin-like modifier-activating enzyme ATG7 isoform X2
vestigial like family member 4, transcript variant X2
vestigial like family member 4, transcript variant X1
transcription cofactor vestigial-like protein 4 isoform X2
transcription cofactor vestigial-like protein 4 isoform X1
TAM41 mitochondrial translocator assembly and maintenance homolog
phosphatidate cytidylyltransferase, mitochondrial
peroxisome proliferator activated receptor gamma, transcript variant X1
peroxisome proliferator activated receptor gamma, transcript variant X2
peroxisome proliferator-activated receptor gamma
tRNA splicing endonuclease subunit 2, transcript variant X1
tRNA splicing endonuclease subunit 2, transcript variant X2
probable E3 ubiquitin-protein ligase makorin-2
Raf-1 proto-oncogene, serine/threonine kinase, transcript variant X4
Raf-1 proto-oncogene, serine/threonine kinase, transcript variant X3
Raf-1 proto-oncogene, serine/threonine kinase, transcript variant X5
Raf-1 proto-oncogene, serine/threonine kinase, transcript variant X1
Raf-1 proto-oncogene, serine/threonine kinase, transcript variant X2
RAF proto-oncogene serine/threonine-protein kinase isoform X2
RAF proto-oncogene serine/threonine-protein kinase isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 19% coverage of the annotated genomic feature by RNAseq alignments
CCHC-type zinc finger nucleic acid binding protein, transcript variant X5
CCHC-type zinc finger nucleic acid binding protein, transcript variant X1
CCHC-type zinc finger nucleic acid binding protein, transcript variant X3
CCHC-type zinc finger nucleic acid binding protein, transcript variant X4
CCHC-type zinc finger nucleic acid binding protein, transcript variant X2
cellular nucleic acid-binding protein isoform X1
cellular nucleic acid-binding protein isoform X2
cellular nucleic acid-binding protein isoform X3
cellular nucleic acid-binding protein isoform X4
ISY1 splicing factor homolog, transcript variant X1
pre-mRNA-splicing factor ISY1 homolog isoform X1
ISY1 splicing factor homolog, transcript variant X3
pre-mRNA-splicing factor ISY1 homolog isoform X3
ISY1 splicing factor homolog, transcript variant X2
pre-mRNA-splicing factor ISY1 homolog isoform X2
haloacid dehalogenase-like hydrolase domain-containing 5, transcript variant X1
haloacid dehalogenase-like hydrolase domain-containing 5, transcript variant X3
haloacid dehalogenase-like hydrolase domain-containing 5, transcript variant X4
haloacid dehalogenase-like hydrolase domain-containing 5, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
haloacid dehalogenase-like hydrolase domain-containing 5 isoform X3
haloacid dehalogenase-like hydrolase domain-containing 5 isoform X1
haloacid dehalogenase-like hydrolase domain-containing 5 isoform X2
RAB43, member RAS oncogene family, transcript variant X2
RAB43, member RAS oncogene family, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins
EF-hand and coiled-coil domain containing 1, transcript variant X3
EF-hand and coiled-coil domain containing 1, transcript variant X2
EF-hand and coiled-coil domain containing 1, transcript variant X1
EF-hand and coiled-coil domain-containing protein 1 isoform X3
EF-hand and coiled-coil domain-containing protein 1 isoform X2
EF-hand and coiled-coil domain-containing protein 1 isoform X1
uncharacterized LOC117002496, transcript variant X1
uncharacterized protein LOC117002496 isoform X1
uncharacterized LOC117002499, transcript variant X3
uncharacterized protein LOC117002499 isoform X3
uncharacterized LOC117002499, transcript variant X2
uncharacterized protein LOC117002499 isoform X2
uncharacterized LOC117002499, transcript variant X1
uncharacterized LOC117002496, transcript variant X2
uncharacterized protein LOC117002499 isoform X1
uncharacterized protein LOC117002496 isoform X2
uncharacterized LOC117002496, transcript variant X4
uncharacterized LOC117002496, transcript variant X5
uncharacterized protein LOC117002496 isoform X4
uncharacterized LOC117002496, transcript variant X3
uncharacterized protein LOC117002496 isoform X3
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 93% coverage of the annotated genomic feature by RNAseq alignments
LOW QUALITY PROTEIN: membrane-anchored junction protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
BICD cargo adaptor 2, transcript variant X2
BICD cargo adaptor 2, transcript variant X3
BICD cargo adaptor 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 ESTs, 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
FYVE, RhoGEF and PH domain containing 3, transcript variant X2
FYVE, RhoGEF and PH domain containing 3, transcript variant X1
FYVE, RhoGEF and PH domain containing 3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 6 ESTs, 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
FYVE, RhoGEF and PH domain-containing protein 3 isoform X1
FYVE, RhoGEF and PH domain-containing protein 3 isoform X2
FYVE, RhoGEF and PH domain containing 3, transcript variant X4
FYVE, RhoGEF and PH domain containing 3, transcript variant X5
FYVE, RhoGEF and PH domain containing 3, transcript variant X6
FYVE, RhoGEF and PH domain-containing protein 3 isoform X3
caspase recruitment domain family member 19, transcript variant X2
caspase recruitment domain-containing protein 19 isoform X2
caspase recruitment domain family member 19, transcript variant X1
caspase recruitment domain-containing protein 19 isoform X1
caspase recruitment domain family member 19, transcript variant X3
caspase recruitment domain-containing protein 19 isoform X3
WNK lysine deficient protein kinase 2, transcript variant X6
WNK lysine deficient protein kinase 2, transcript variant X7
WNK lysine deficient protein kinase 2, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 ESTs, 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
WNK lysine deficient protein kinase 2, transcript variant X1
WNK lysine deficient protein kinase 2, transcript variant X3
WNK lysine deficient protein kinase 2, transcript variant X4
WNK lysine deficient protein kinase 2, transcript variant X5
WNK lysine deficient protein kinase 2, transcript variant X10
WNK lysine deficient protein kinase 2, transcript variant X2
WNK lysine deficient protein kinase 2, transcript variant X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 ESTs, 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
WNK lysine deficient protein kinase 2, transcript variant X8
WNK lysine deficient protein kinase 2, transcript variant X9
serine/threonine-protein kinase WNK2 isoform X8
serine/threonine-protein kinase WNK2 isoform X9
serine/threonine-protein kinase WNK2 isoform X11
serine/threonine-protein kinase WNK2 isoform X1
serine/threonine-protein kinase WNK2 isoform X6
serine/threonine-protein kinase WNK2 isoform X7
serine/threonine-protein kinase WNK2 isoform X3
serine/threonine-protein kinase WNK2 isoform X4
serine/threonine-protein kinase WNK2 isoform X5
serine/threonine-protein kinase WNK2 isoform X10
serine/threonine-protein kinase WNK2 isoform X2
serine/threonine-protein kinase WNK2 isoform X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
family with sequence similarity 120A, transcript variant X2
family with sequence similarity 120A, transcript variant X1
family with sequence similarity 120A, transcript variant X3
constitutive coactivator of PPAR-gamma-like protein 1 isoform X1
constitutive coactivator of PPAR-gamma-like protein 1 isoform X3
constitutive coactivator of PPAR-gamma-like protein 1 isoform X2
PHD finger protein 2, transcript variant X2
PHD finger protein 2, transcript variant X1
lysine-specific demethylase PHF2 isoform X2
lysine-specific demethylase PHF2 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 33% coverage of the annotated genomic feature by RNAseq alignments
protein tyrosine phosphatase domain containing 1, transcript variant X1
protein tyrosine phosphatase domain-containing protein 1 isoform X1
protein tyrosine phosphatase domain containing 1, transcript variant X2
protein tyrosine phosphatase domain containing 1, transcript variant X4
protein tyrosine phosphatase domain containing 1, transcript variant X3
protein tyrosine phosphatase domain-containing protein 1 isoform X2
protein tyrosine phosphatase domain containing 1, transcript variant X5
protein tyrosine phosphatase domain-containing protein 1 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 94% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC117002594, transcript variant X2
uncharacterized LOC117002594, transcript variant X1
uncharacterized LOC117002594, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins
histone deacetylase 11, transcript variant X5
histone deacetylase 11, transcript variant X4
histone deacetylase 11, transcript variant X3
histone deacetylase 11, transcript variant X1
histone deacetylase 11, transcript variant X2
IQ motif and Sec7 domain ArfGEF 1, transcript variant X14
IQ motif and Sec7 domain ArfGEF 1, transcript variant X1
IQ motif and Sec7 domain ArfGEF 1, transcript variant X3
IQ motif and Sec7 domain ArfGEF 1, transcript variant X4
IQ motif and Sec7 domain ArfGEF 1, transcript variant X2
IQ motif and Sec7 domain ArfGEF 1, transcript variant X5
IQ motif and Sec7 domain ArfGEF 1, transcript variant X10
IQ motif and Sec7 domain ArfGEF 1, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 ESTs, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
IQ motif and Sec7 domain ArfGEF 1, transcript variant X12
IQ motif and SEC7 domain-containing protein 1 isoform X10
IQ motif and SEC7 domain-containing protein 1 isoform X14
IQ motif and SEC7 domain-containing protein 1 isoform X1
IQ motif and SEC7 domain-containing protein 1 isoform X3
IQ motif and SEC7 domain-containing protein 1 isoform X4
IQ motif and SEC7 domain-containing protein 1 isoform X2
IQ motif and SEC7 domain-containing protein 1 isoform X5
IQ motif and SEC7 domain-containing protein 1 isoform X11
IQ motif and SEC7 domain-containing protein 1 isoform X12
IQ motif and Sec7 domain ArfGEF 1, transcript variant X7
IQ motif and Sec7 domain ArfGEF 1, transcript variant X9
IQ motif and SEC7 domain-containing protein 1 isoform X7
IQ motif and SEC7 domain-containing protein 1 isoform X9
IQ motif and Sec7 domain ArfGEF 1, transcript variant X6
IQ motif and SEC7 domain-containing protein 1 isoform X6
IQ motif and Sec7 domain ArfGEF 1, transcript variant X8
IQ motif and Sec7 domain ArfGEF 1, transcript variant X13
IQ motif and SEC7 domain-containing protein 1 isoform X13
IQ motif and SEC7 domain-containing protein 1 isoform X8
complex I assembly factor ACAD9, mitochondrial
proline-rich receptor-like protein kinase PERK1, transcript variant X1
proline-rich receptor-like protein kinase PERK1, transcript variant X2
proline-rich receptor-like protein kinase PERK1 isoform X2
proline-rich receptor-like protein kinase PERK1 isoform X1
EF-hand and coiled-coil domain-containing protein 1-like
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 92% coverage of the annotated genomic feature by RNAseq alignments
LOW QUALITY PROTEIN: EF-hand and coiled-coil domain-containing protein 1-like